GreenLight Biosciences (GRNAW)
NASDAQ: GRNAW
· Real-Time Price · USD
0.02
-0.00 (-0.99%)
At close: Jul 21, 2023, 6:10 PM
GreenLight Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -157.32M | -167.06M | -65.71M | -56.74M | -31.98M | -15.06M | -95.13M | -65.94M | -38.77M |
Depreciation & Amortization | 8.31M | 8.08M | 5.88M | 5.49M | 4.66M | 3.67M | 4.29M | 2.92M | 1.73M |
Stock-Based Compensation | 8.96M | 8.84M | 6.52M | 4.36M | 3.13M | 1.29M | 1.51M | 972K | 565K |
Other Working Capital | 10.92M | 10.02M | 17.53M | 27.07M | -5.73M | 2.08M | 1.82M | -1.74M | -1.72M |
Other Non-Cash Items | 5.23M | 5M | -4.81M | -4.07M | -2.47M | -2.95M | 2.37M | 913K | 500K |
Deferred Income Tax | n/a | n/a | n/a | 1.14M | 1.34M | 1.34M | 1.34M | 194K | -7K |
Change in Working Capital | 16.49M | 8.41M | 11.41M | 19.29M | -3.25M | 11.24M | 3.08M | 2.21M | -2.01M |
Operating Cash Flow | -118.32M | -136.73M | -46.71M | -31.67M | -29.92M | -1.81M | -83.87M | -58.93M | -37.99M |
Capital Expenditures | -27.87M | -26.55M | -22.94M | -17.45M | -6.96M | -11.36M | -13.91M | -9.33M | -7.23M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 37K | 37K | 37K | 37K | n/a | n/a | n/a | n/a |
Investing Cash Flow | -27.87M | -26.51M | -218.54M | -213.05M | -202.56M | -207M | -13.91M | -9.33M | -7.23M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 95.41M | 200.85M | 393.26M | 300.92M | 308.54M | 208.72M | 18.18M | 6.25M | 2.44M |
Financial Cash Flow | 95.41M | 200.85M | 393.26M | 300.92M | 308.54M | 208.72M | 18.18M | 6.25M | 2.44M |
Net Cash Flow | -50.78M | 37.61M | 33.01M | -38.79M | -18.93M | -95.08M | -79.59M | -62.01M | -42.78M |
Free Cash Flow | -146.19M | -163.28M | -69.65M | -49.12M | -36.88M | -13.17M | -97.78M | -68.26M | -45.22M |